Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |